Tejon Ranch Co.
NYSE:TRCConglomerates
-$0.06 today
- Market cap
- $465.26M
- Beta
- 0.59
- P/E (TTM)
- 296.5
- EPS (TTM)
- $0.06
Volume 0.26M
Average 0.09M
TRC Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Tejon Ranch Co.NYSE: TRC
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $3.14M rose 209.3% year over year, ahead of the +104.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 23.6% from the prior quarter. Over 3 fiscal years it compounded at +9.1% a year.
Context
- Depreciation & amortization amounted to 12.1% of revenue in FY2025, up 0.5 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +209.3% holds above the trailing-twelve-month pace of +104.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 6.01M USD
- Year-over-year change
- +23.1%
- 4-year CAGR
- +7.0%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.01M | +23.1% |
| FY2024 | 2024-12-31 | 4.89M | +1.6% |
| FY2023 | 2023-12-31 | 4.81M | +3.8% |
| FY2022 | 2022-12-31 | 4.63M | +0.7% |
| FY2021 | 2021-12-31 | 4.59M | — |
Depreciation & Amortization vs competitors
How TRC compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +104.9% is the 2nd highest of 9, against a peer median of -0.0%.
- Depreciation & amortization amounts to 19.7% of revenue for TRC, versus a peer median of 3.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $146.4M USD | +5.3% | +24.0% | 9.5% | |
| LTM Mar 2026 | $137.56M USD | -5.4% | +7.3% | 7.4% | |
| LTM Mar 2026 | $27.25M USD | -5.9% | +15.6% | 12.0% | |
| LTM Mar 2026 | $26.06M USD | +17.6% | +8.3% | 3.0% | |
| LTM Mar 2026 | $10.03M USD | +104.9% | +9.1% | 19.7% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $9.55M USD | +57.4% | +6.4% | 3.8% |
| LTM Mar 2026 | $9.18M USD | -10.2% | -13.1% | 1.1% | |
| LTM Mar 2026 | £2.88M GBP | — | -3.6% | — | |
| LTM Mar 2026 | $479K USD | +5222.2% | -22.1% | 2.6% | |
| LTM Apr 2026 | -$16.47M USD | -151.7% | — | 3.1% | |
| Peer median (excluding TRC) | — | -0.0% | +6.9% | 3.4% | |
Competitors are the stored peer set for TRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 55.61M | 79.22M | 44.74M | 41.89M | 49.59M |
| Cost of Revenue | 46.03M | 55.79M | 38.57M | 39.99M | 43.48M |
| Gross Profit | 9.58M | 23.43M | 6.17M | 1.89M | 6.11M |
| Gross Margin | 17.2% | 29.6% | 13.8% | 4.5% | 12.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 9.84M | 9.7M | 0 | 11.09M | 0 |
| Operating Expenses | 9.84M | 9.7M | 9.87M | 11.09M | 14.07M |
| Depreciation & Amortization | 4.59M | 4.63M | 4.81M | 4.89M | 6.01M |
| EBITDA | 13.76M | 27.83M | 10.39M | 8.55M | 7.17M |
| EBITDA Margin | 24.7% | 35.1% | 23.2% | 20.4% | 14.5% |
| Operating Income | (260K) | 13.73M | (3.7M) | (9.2M) | (7.95M) |
| Operating Margin | -0.5% | 17.3% | -8.3% | -22.0% | -16.0% |
| Interest Income | 0 | 0 | 0 | 2.27M | 914K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 9.42M | 9.47M | 9.29M | 12.86M | 9.11M |
| Income Before Tax | 9.16M | 23.2M | 5.59M | 3.66M | 1.16M |
| Pre-Tax Margin | 16.5% | 29.3% | 12.5% | 8.7% | 2.3% |
| Income Tax Expense | 3.82M | 7.39M | 2.32M | 976K | 1.09M |
| Net Income | 5.35M | 15.81M | 3.27M | 2.69M | 75K |
| Net Margin | 9.6% | 20.0% | 7.3% | 6.4% | 0.2% |
| EPS (Basic) | 0.20 | 0.60 | 0.12 | 0.10 | 0.00 |
| EPS (Diluted) | 0.20 | 0.59 | 0.12 | 0.10 | 0.00 |
| Weighted Avg Shares | 26.34M | 26.48M | 26.71M | 26.81M | 26.95M |
| Weighted Avg Shares (Diluted) | 26.41M | 26.65M | 26.71M | 26.82M | 26.95M |
Tejon Ranch Co.
NYSE:TRC
Intrinsic Alpha fair value
Locked
Current Price
$17.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.